Cargando…

Breast Cancer Stem Cells with Tumor- versus Metastasis-Initiating Capacities Are Modulated by TGFBR1 Inhibition

Cancer stem cells (CSCs) are defined by their ability to regenerate a tumor upon transplantation. However, it is not yet clear whether tumors contain a single CSC population or different subsets of cells with mixed capacities for initiating primary and secondary tumors. Using two different identific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fico, Flavia, Bousquenaud, Mélanie, Rüegg, Curzio, Santamaria-Martínez, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626885/ https://www.ncbi.nlm.nih.gov/pubmed/31257133 http://dx.doi.org/10.1016/j.stemcr.2019.05.026

Ejemplares similares

Obesity promotes the expansion of metastasis-initiating cells in breast cancer
por: Bousquenaud, Mélanie, et al.
Publicado: (2018)

TGFBI modulates tumour hypoxia and promotes breast cancer metastasis
por: Fico, Flavia, et al.
Publicado: (2020)

Emodin Inhibits Inflammation, Carcinogenesis, and Cancer Progression in the AOM/DSS Model of Colitis-Associated Intestinal Tumorigenesis
por: Zhang, Yunsha, et al.
Publicado: (2021)

The Tumor Microenvironment as a Driving Force of Breast Cancer Stem Cell Plasticity
por: Fico, Flavia, et al.
Publicado: (2020)

MAGI1 Mediates eNOS Activation and NO Production in Endothelial Cells in Response to Fluid Shear Stress
por: Ghimire, Kedar, et al.
Publicado: (2019)

Beauvericin suppresses the proliferation and pulmonary metastasis of osteosarcoma by selectively inhibiting TGFBR2 pathway
por: Ye, Geni, et al.
Publicado: (2023)

Characterization and In Vivo Validation of a Three-Dimensional Multi-Cellular Culture Model to Study Heterotypic Interactions in Colorectal Cancer Cell Growth, Invasion and Metastasis
por: Cattin, Sarah, et al.
Publicado: (2018)

Mechanism of irradiation‐induced mammary cancer metastasis: A role for SAP‐dependent Mkl1 signaling
por: Asparuhova, Maria B., et al.
Publicado: (2015)

WFDC3 inhibits tumor metastasis by promoting the ERβ-mediated transcriptional repression of TGFBR1 in colorectal cancer
por: Liu, Tianqi, et al.
Publicado: (2023)

MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer
por: Alday-Parejo, Begoña, et al.
Publicado: (2020)

The Tumor Suppressor TGFBR3 Blocks Lymph Node Metastasis in Head and Neck Cancer
por: Fang, Wei-Yu, et al.
Publicado: (2020)

The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis
por: Huang, Yu-Ting, et al.
Publicado: (2016)

MicroRNA-98-5p inhibits proliferation and metastasis in non-small cell lung cancer by targeting TGFBR1
por: Jiang, Feng, et al.
Publicado: (2018)

Surgical Outcome and Histological Differences between Individuals with TGFBR1 and TGFBR2 Mutations in Loeys-Dietz Syndrome
por: Seike, Yoshimasa, et al.
Publicado: (2021)

The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication
por: Wörthmüller, Janine, et al.
Publicado: (2020)

MAGI1, a Scaffold Protein with Tumor Suppressive and Vascular Functions
por: Wörthmüller, Janine, et al.
Publicado: (2021)

Allele-specific expression of TGFBR1 in colon cancer patients
por: Tomsic, Jerneja, et al.
Publicado: (2010)

Sequencing of NOTCH1, GATA5, TGFBR1 and TGFBR2 genes in familial cases of bicuspid aortic valve
por: Foffa, Ilenia, et al.
Publicado: (2013)

In silico analysis of the potential effects of the disease-associated point mutations on the kinase activity of TGFBR1 and TGFBR2 receptors
por: Rougé, Pierre, et al.
Publicado: (2014)

Luteolin Inhibits Vascular Smooth Muscle Cell Proliferation and Migration by Inhibiting TGFBR1 Signaling
por: Wu, Yu-Ting, et al.
Publicado: (2018)

LINC00052 promotes breast cancer cell progression and metastasis by sponging miR-145-5p to modulate TGFBR2 expression
por: Dong, Menglu, et al.
Publicado: (2021)

Metabolic dependencies of metastasis-initiating cells in female breast cancer
por: Young, C. Megan, et al.
Publicado: (2023)

Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs
por: Pasche, Boris, et al.
Publicado: (2010)

Associations of TGFBR1 and TGFBR2 gene polymorphisms with the risk of hypospadias: a case–control study in a Chinese population
por: Han, Xin-Rui, et al.
Publicado: (2017)

Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition
por: Gao, Lei, et al.
Publicado: (2019)

Radiotherapy Suppresses Angiogenesis in Mice through TGF-βRI/ALK5-Dependent Inhibition of Endothelial Cell Sprouting
por: Imaizumi, Natsuko, et al.
Publicado: (2010)

Dual CSF1R inhibition and CD40 activation demonstrates anti-tumor activity in a 3D macrophage- HER2(+) breast cancer spheroid model
por: Rodriguez-Perdigon, Manuel, et al.
Publicado: (2023)

Retraction: Associations of TGFBR1 and TGFBR2 gene polymorphisms with the risk of hypospadias: a case-control study in a Chinese population
Publicado: (2022)

A Tgfbr1/Snai1-dependent developmental module at the core of vertebrate axial elongation
por: Dias, André, et al.
Publicado: (2020)

Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
por: Lorusso, Girieca, et al.
Publicado: (2020)

Targeting BRAF-mutant tumours with TGFBR1 inhibitors
por: Spender, Lindsay C, et al.
Publicado: (2017)

TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk
por: Skoglund Lundin, J, et al.
Publicado: (2009)

Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway
por: Zhou, Bin, et al.
Publicado: (2018)

The Integrin Antagonist Cilengitide Activates αVβ3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells
por: Alghisi, Gian Carlo, et al.
Publicado: (2009)

Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
por: Alday-Parejo, Begoña, et al.
Publicado: (2019)

GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma
por: Fang, Zhiqing, et al.
Publicado: (2022)

Relationship between the TGFBR1 Gene and Molar Incisor Hypomineralization
por: Georgina-Pérez, Laura, et al.
Publicado: (2023)

E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer
por: López-Menéndez, Celia, et al.
Publicado: (2021)

Clinical utility of TGFB1 and its receptors (TGFBR1 and TGFBR2) in thyroid nodules: evaluation based on single nucleotide polymorphisms and mRNA analysis
por: Peres, Karina Colombera, et al.
Publicado: (2021)

Human bone marrow mesenchymal stem cell-derived extracellular vesicles inhibit shoulder stiffness via let-7a/Tgfbr1 axis
por: Luo, Zhiwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rtok284mgpq9nod4sh0sthkcsh